Literature DB >> 15537650

Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.

Alessandra Fontanini1, Romina Chies, Erik L Snapp, Moreno Ferrarini, Gian Maria Fabrizi, Claudio Brancolini.   

Abstract

Missense point mutations in Gas3/PMP22 are responsible for the peripheral neuropathies Charcot-Marie-Tooth 1A and Dejerine Sottas syndrome. These mutations induce protein misfolding with the consequent accumulation of the proteins in the endoplasmic reticulum and the formation of aggresomes. During folding, Gas3/PMP22 associates with the lectin chaperone calnexin. Here, we show that calnexin interacts with the misfolded transmembrane domains of Gas3/PMP22, fused to green fluorescent protein, in a glycan-independent manner. In addition, photobleaching experiments in living cells revealed that Gas3/PMP22-green fluorescent protein mutants are mobile but diffuse at almost half the diffusion coefficient of wild type protein. Our results support emerging models for a glycan-independent chaperone role for calnexin and for the mechanism of retention of misfolded membrane proteins in the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537650     DOI: 10.1074/jbc.M405104200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Endoplasmic reticulum architecture: structures in flux.

Authors:  Nica Borgese; Maura Francolini; Erik Snapp
Journal:  Curr Opin Cell Biol       Date:  2006-06-27       Impact factor: 8.382

2.  Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies.

Authors:  Vladimir M Korkhov; Laura Milan-Lobo; Benoît Zuber; Hesso Farhan; Johannes A Schmid; Michael Freissmuth; Harald H Sitte
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

3.  Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease.

Authors:  Masayoshi Sakakura; Arina Hadziselimovic; Zhen Wang; Kevin L Schey; Charles R Sanders
Journal:  Structure       Date:  2011-08-10       Impact factor: 5.006

4.  The safety dance: biophysics of membrane protein folding and misfolding in a cellular context.

Authors:  Jonathan P Schlebach; Charles R Sanders
Journal:  Q Rev Biophys       Date:  2014-11-25       Impact factor: 5.318

Review 5.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

6.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

7.  The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized.

Authors:  Jeffrey K Myers; Charles K Mobley; Charles R Sanders
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

8.  Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum.

Authors:  Rowena R Ramos; Andrea J Swanson; Joseph Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

9.  Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome.

Authors:  Maria-Carmen Serrano-Perez; Frances C Tilley; Fabien Nevo; Christelle Arrondel; Selim Sbissa; Gaëlle Martin; Kalman Tory; Corinne Antignac; Géraldine Mollet
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

10.  PP2A regulates HDAC4 nuclear import.

Authors:  Gabriela Paroni; Nadia Cernotta; Claudio Dello Russo; Paola Gallinari; Michele Pallaoro; Carmela Foti; Fabio Talamo; Laura Orsatti; Christian Steinkühler; Claudio Brancolini
Journal:  Mol Biol Cell       Date:  2007-11-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.